Bone cancer pain is a multifactorial process with many potential targets for therapeutic intervention. As pain is the most common presenting symptom in patients with skeletal metastases and is directly proportional to the patient's quality of life, clinical improvements in the treatment of bone cancer pain are of the utmost importance. Research targeting pain-related cytokines, anti-osteoclastic medications, and ion channels have shown significant clinical progress in the treatment of cancer-related bone pain. With continued efforts into these and other therapeutic strategies, we hope to continue to improve the quality of life of those patients suffering with bone cancer pain.
|Original language||English (US)|
|Title of host publication||Bone Cancer|
|Subtitle of host publication||Primary Bone Cancers and Bone Metastases: Second Edition|
|Number of pages||7|
|State||Published - Jan 1 2015|
- Bone cancer
- Skeletal mestastasis